Hospitalized COVID-19 Patients with a 25-hydroxyvitamin D blood level of at least 30 ng / mL (a measure of vitamin D status) had a significant reduction in risk for adverse clinical outcomes such as hypoxia (starvation for the body). Oxygen) and death. In addition, they had low blood levels of inflammatory markers (C-reactive proteins) and low blood levels of lymphocytes (a type of immune cell to help fight infection).
“This study provides direct evidence that vitamin D supplementation can reduce complications, including cytokine turbulence (many proteins are released too quickly into the blood) and eventually death from COVID-19,” corresponding author Michael F. Holick, Ph.D., M.D., Professor of Medicine, Physiology and Biophysics and Molecular Medicine at Boston University School of Medicine.
Blood samples were taken to measure vitamin D status (measured serum levels of 25-hydroxyvitamin D), of which 235 patients were hospitalized with COVID-19. These patients were followed for clinical outcomes, including clinical severity of infection, fainting, hypoxia, and difficulty breathing as a result of death. Blood was also analyzed for inflammatory markers (C-reactive proteins) and a number of lymphocytes. The researchers then compared all of these parameters in patients who had adequate amounts of vitamin D in patients with vitamin D deficiency.
In patients over the age of 0 years, they found that those with vitamin D deficiency or those with less than 25-hydroxyvitamin D blood levels less than were0-ng had 51.5 percent less vitamin D. M.L.
Hollick, who recently published a study that found that adequate amounts of vitamin D can reduce the risk of catching coronavirus by one percent, believes that having enough vitamin D results in infection with not only coronavirus but other viruses. Helps fight. Causes of upper respiratory tract diseases, including influenza. “The big concern here is that the combination of influenza infection and coronal viral infection can significantly increase hospital admissions and deaths due to complications from this viral infection.”
According to Holick, the study provides a simple and inexpensive-effective strategy to improve the ability to fight coronavirus and reduce the adverse clinical outcomes of Contivide-19, which requires ventilator support, an overactive immune response leading to cytokine storm and death. . “Because vitamin D deficiency and deficiency is widespread in children and adults in the United States and around the world, especially during the winter months, it is prudent for everyone to take vitamin D supplements to reduce the risk of infection and complications from COVID.” . ”
Reference: “Vitamin D adequacy, serum 25-hydroxyvitamin D at least 30 ng / mL reduces the risk of adverse clinical outcomes in patients with COMIT-19 infection” , Azar Hadadi, Mehnaz Montazeri, Mehrad Nasiri, Arash Shirwani and Michael F. Holick, 25 September 2520, Plaza one.
DOI: 10.1371 / journal.pon.0239799
